Laura Seaman
Family · Lebanon, MONPI 1013321306
Payments from drug & device makers
Across 116 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$283
- Lilly USA, LLC$235
- Merck$155
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$118
- Abbott$111
- Amgen$108
- plus $824 from 20 others
What the payments were for
- Food & beverage$1,833100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $283 |
| Lilly USA, LLC | 15 | $235 |
| Merck | 10 | $155 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $118 |
| Abbott | 5 | $111 |
| Amgen | 7 | $108 |
| Pfizer | 7 | $108 |
| AbbVie | 6 | $106 |
| AstraZeneca | 5 | $92 |
| Bayer | 5 | $72 |
| GSK | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Dexcom, Inc. | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Acadia Pharmaceuticals Inc | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Radius Health, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Edwards Lifesciences | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Novartis | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,833 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 77 | $96,492 |
| JardianceEmpagliflozin | 51 | $51,604 |
| VraylarCariprazine Hcl | 25 | $41,652 |
| JanuviaSitagliptin Phosphate | 26 | $28,300 |
| TrulicityDulaglutide | 23 | $23,265 |
| EliquisApixaban | 20 | $17,397 |
| XareltoRivaroxaban | 11 | $11,995 |
| MyrbetriqMirabegron | 20 | $9,855 |
| Spiriva RespimatTiotropium Bromide | 16 | $8,373 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $6,440 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $6,157 |
| Vilazodone Hcl | 16 | $2,648 |
| Gabapentin | 149 | $2,034 |
| Humalog Kwikpen U-100Insulin Lispro | 12 | $1,928 |
| Levemir FlexpenInsulin Detemir | 11 | $1,797 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $283 | $96,49277 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $19 | $66,41781 claims |
| AbbVieVraylar | $106 | $41,65225 claims |
| MerckJanuvia | $155 | $28,30026 claims |
| Lilly USA, LLCTrulicity | $235 | $23,26523 claims |
| PfizerEliquis | $108 | $17,39720 claims |
| Johnson & JohnsonXarelto | $14 | $11,99511 claims |
| AstraZenecaSymbicort | $92 | $6,15716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.
Other family in Lebanon
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.